Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Risperidone: clinical safety and efficacy in schizophrenia.

Borison RL, Pathiraja AP, Diamond BI, Meibach RC.

Psychopharmacol Bull. 1992;28(2):213-8.

PMID:
1381102
2.

Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.

Huttunen MO, Piepponen T, Rantanen H, Larmo I, Nyholm R, Raitasuo V.

Acta Psychiatr Scand. 1995 Apr;91(4):271-7.

PMID:
7542829
3.
4.

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.

J Clin Psychopharmacol. 1993 Feb;13(1):25-40. Erratum in: J Clin Psychopharmacol 1993 Apr;13(2):149.

PMID:
7683702
5.

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.

Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peuskens J, Heylen S.

Acta Psychiatr Scand. 1992 Apr;85(4):295-305.

PMID:
1375801
6.

Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.

Möller HJ, Pelzer E, Kissling W, Riehl T, Wernicke T.

Pharmacopsychiatry. 1991 Nov;24(6):185-9.

PMID:
1725925
7.

Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.

Klieser E, Lehmann E, Kinzler E, Wurthmann C, Heinrich K.

J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):45S-51S.

PMID:
7537287
8.

Risperidone: clinical development: north American results.

Marder SR.

Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:92A-93A.

PMID:
1379883
9.

Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study.

Chouinard G.

J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):36S-44S.

PMID:
7537286
10.

Schizophrenia and severe tardive dyskinesia responsive to risperidone.

Kopala LC, Honer WG.

J Clin Psychopharmacol. 1994 Dec;14(6):430-1. No abstract available.

PMID:
7533794
13.

Clinical review of risperidone.

Chouinard G, Arnott W.

Can J Psychiatry. 1993 Sep;38 Suppl 3:S89-95. Review.

PMID:
7504574
14.

Desmopressin for risperidone-induced enuresis.

Bennett JA, Keck PE Jr, Wallhausser LJ.

Ann Clin Psychiatry. 1994 Jun;6(2):139-40. No abstract available.

PMID:
7528602
15.

Efficacy of risperidone on positive features of schizophrenia.

McEvoy JP.

J Clin Psychiatry. 1994 May;55 Suppl:18-21.

PMID:
7520904
16.

Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.

Chouinard G, Vainer JL, Bélanger MC, Turnier L, Beaudry P, Roy JY, Miller R.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Nov;18(7):1129-41.

PMID:
7531355
17.

Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.

Weiden PJ, Cutler AJ, Polymeropoulos MH, Wolfgang CD.

J Clin Psychopharmacol. 2008 Apr;28(2 Suppl 1):S12-9. doi: 10.1097/JCP.0b013e3181694f5a.

PMID:
18334908
18.

Clinical considerations in the use of risperidone.

Remington GJ.

Can J Psychiatry. 1993 Sep;38 Suppl 3:S96-100. Review.

PMID:
7504575
19.

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations.

Høyberg OJ, Fensbo C, Remvig J, Lingjaerde O, Sloth-Nielsen M, Salvesen I.

Acta Psychiatr Scand. 1993 Dec;88(6):395-402.

PMID:
7508675
20.

Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients.

Wilms G, Van Ongeval C, Baert AL, Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peuskens J, Heylen S.

Acta Psychiatr Scand. 1992 Apr;85(4):306-12.

PMID:
1375802

Supplemental Content

Support Center